Susan Hasty, Publisher
Table of Contents . . . November 20th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in TB and Outbreaks Week | Other Publications
Mycobacteria - Alternate Sigma Factor Plays Key Role In Bacterial Stress Responses
Nosocomial Infections - Antimicrobial Overuse Contributes To Acinetobacter anitratus Outbreaks
AIDS And HIV Tuberculosis - Coinfection Does Not Appear To Augment TB Infectivity
Bioterrorism - Los Alamos Lab Is Doing Anthrax Study
Pathology - Researchers Discover Infectious Mechanism Common To Many Bacteria
Tuberculosis Epidemiology - Casual Infectious Contacts May Be Missed By Conventional Tracing Methods
Tuberculosis Therapy - Isoniazid Hepatotoxicity Not Increased In Hepatitis C Patients
Anthrax - Bayer, HHS Complete Cipro Agreement
Anthrax - BioPort May Resume Vaccine Production By End Of November
Anthrax - Kaiser Permanente Practice Guidelines Available To Health Care Organizations
Anthrax - King Pharmaceuticals To Increase Production Of Wycillin
Anthrax - Pathologist Group Helps CDC Disseminate Bioterrorism Protocols To Labs
Anthrax - Xenon Asserts Bacteria Can Be Killed With SteriPulse One Second UV Pulses
At-Risk Populations - African-American Physicians Group Issues Hepatitis Guidelines
Bacterial Conjunctivitis - Educational Initiative Discusses Advances In Ophthalmic Fluoroquinolones
Biological Warfare - ACE Hardware to Sell VLPI's Anthrax Test Nationwide
Biological Warfare - IGEN s Collaboration With U.S. Army On Toxins Gets New Emphasis
Bioterrorism - Cannot Ignore Need To Eradicate HIV/AIDs, Tuberculosis, Official Says
Bioterrorism - Cycling Probe Technology Used In Detection Of Biological Agents
Bioterrorism - Drug Companies Offer Skills To Combat Chemical, Germ Warfare
Bioterrorism - Panel Suggests Federally Supervised Vaccine Labs
Bioterrorism - Vacudyne, Sterilization Services Offer Proven Method To Kill Anthrax
Bioterrorism - Washington, DC, Veterans Center Tests For Anthrax
Chagas Disease - Cerus, Baxter Report Inactivation Of Trypanosoma Cruzi Parasite
Cystic Fibrosis - Inhaled Antibiotic For Chronic Lung Infections Goes To Trial
Cystic Fibrosis - Mucoregulator Therapy Attacks Mucus Overproduction
Diagnostics - Genaco To Develop Diagnostic Assays Based On Luminex Technology
Drug Resistance - Anthrax-Fighting Drugs Apt To Spur Resistance In Common Bugs
Finance - Genecor Reports Flat Revenues, Decreased Earnings In 3rd Quarter
Food Safety - Bioniche Funds $4 Million Research Chair At University Of Saskatchewan
Foot and Mouth Disease - Inactine System Inactivates Nonenveloped Viruses
Gram-Positive Bacteria - Daptomycin Trial Achieves Primary Efficacy Endpoint
Infectious Disease - Microbiotix Awarded SBIR Grant To Expand Antibiotics Screening Program
Influenza - Prevention Tips From The University Of Pittsburgh
Influenza - Shire Biologics Contracts With Canadian Government To Prevent Pandemic
Meningococcal Group C Vaccine - Shire Biologics Signs Distribution Pack With Baxter Corp.
Respiratory Syncytial Virus - Prophylaxis Reduces Hospitalizations In High-Risk Infants
Smallpox - Aventis Announces Support For Government Emergency Preparedness Efforts
Smallpox - Drug Firms Confirm They May Be Chosen To Develop Vaccine
Streptococcus Pneumoniae - Drug Resistance And Mortality Rising In Elderly Populations
Wound Healing - Warming Therapies Decrease Postoperative Wound Infection
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.